Discovery and Evaluation of BMS-986260, a Potent, Selective and Orally Bioavailable TGFbetaR1 Inhibitor as an Immuno-Oncology Agent U. Velaparthi, C. Darne, J. Warrier, P. Liu, H. Rahaman,J. Fargnoli, K. Augustine-Rauch, K. Parrish, J. Swanson,J. Brown, A. Murtaza, A.J. Tebben, S. Sheriff, M. Ruzanov,C. Yan, M. Gelman,R. Singh, G.D. Vite, R.M. BorzilleriACS Medicinal Chemistry Letters（2020）引用 0|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
